stella
beta
Artificial Intelligence in Molecular Imaging: Predicting Parkinson's Risk in REM Sleep Behavior Disorder — Stella
Home
/
Parkinson Disease
/
Artificial Intelligence in Molecular Imaging: Predicting Parkinson's Risk in REM Sleep Behavior Disorder
View on ClinicalTrials.gov
Recruiting
Back to Parkinson Disease trials
Artificial Intelligence in Molecular Imaging: Predicting Parkinson's Risk in REM Sleep Behavior Disorder
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations
(1 site)
Switzerland
Inselspital, University Clinic for Nuclear Medicine, Bern